Commentary on: “Measuring Patient-Reported Outcomes After Facial Paralysis Reconstruction Surgery Using the Face-Q” by Vicente-Ruiz et al

Vincente-Ruiz M , Hontanilla B . Measuring patient-reported outcomes after facial paralysis reconstruction surgery using the FACE-Q. Facial Plast Surg Aesthet Med 202; In Press; doi: 10.1089/fpsam.2023.0022

Ho AL , Scott AM , Klassen AF , et al. Measuring quality of life and patient satisfaction in facial paralysis patients: A systematic review of patient- reported outcome measures. Plast Reconstr Surg, 2012; 130(1):91–99; doi: 10.1097/PRS.0b013e318254b08d

Borodic G , Bartley M , Slattery W , et al. Botulinum toxin for aberrant facial nerve regeneration: Double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg, 2005; 116:36–43.

Klassen AF , Rae C , Gallo L , et al. Psychometric validation of the FACE-Q craniofacial module for facial nerve paralysis. Facial Plast Surg Aesthet Med, 2022; 24(1):1–7; doi: 10.1089/fpsam.2020.0575

Lyford-Pike S. Commentary on ‘‘Psychometric Validation of the FACE-Q Craniofacial Module for Facial Nerve Palsy’’ by Klassen et al: Should we reinvent the wheel?. Facial Plast Surg Aesthet Med, 2021; 24(1):8–9; doi: 10.1089/fpsam.2021.0017

Lee LN , McCarty JC , Gadkaree SK , et al. Effect of filler therapy on psychosocial distress in facial paralysis: Patients with major asymmetry derive greater benefit. Facial Plast Surg Aesthet Med, 2022; doi: 10.1089/fpsam.2022.0259

Gallo L , Kim P , Yuan M , et al. Best practices for FACE-Q Aesthetics Research: A systematic review of study methodology. Aesthet Surg J, 2023:sjad141; In Press; doi: 10.1093/asj/sjad141